A small and financially opaque drug research nonprofit group based in Ohio has managed to get its research cited extensively in high-prestige publications such as the New York Times, Wall Street ...
A top federal health official is again touting the therapeutic “promise” of psychedelics such as psilocybin and MDMA—though ...
The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has grappled with how to handle new vaccine guidance. The agency has changed — five ...
An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
Nvidia CEO Jensen Huang predicted Wednesday that drug research will shift from traditional labs to AI platforms, with pharma giants already making the leap. Why it matters: The industry is betting the ...
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk ...
AUSTIN, Texas — Texas veterans and researchers are hopeful after the state recently became the first in the nation to pledge public money toward researching ibogaine, a plant-based psychedelic drug ...
Florida State University is looking to participate in what could be a groundbreaking drug discovery study through a ...
CMS recently announced the next 15 drugs that will be subject to price negotiations under the Inflation Reduction Act of 2022 (IRA). These are negotiations in name only because CMS can levy penalties ...
Time to re-up that AARP subscription. A popular prescription drug already in millions of medicine cabinets could be the key to unlocking a longer life for women. New research published in the Journal ...
DUBLIN--(BUSINESS WIRE)--The "Orphan Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Orphan Drugs was estimated at US$179.5 ...